Due to the important involvements of LSD1 in carcinogenesis, and to the numerous ways with which it interferes with various signaling pathways, targeting lysine demethylases and in particular LSD1 is becoming a promising treatment option for cancer patients. Here, KDM1A is linked to cancer.